RTA Laboratuvarları Biyoloji Anonim Şirketi (RTALB)
Market Closed
10 Aug, 15:00
XIST XIST Primary ₺
2. 86
-0.16
-5.298%
₺
1.75B Market Cap
5.16 P/E Ratio
- Div Yield
31.77M Volume
0 Eps
₺ 3.02
Previous Close Want to track RTALB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
RTA Laboratuvarları Biyoloji Anonim Şirketi (RTALB) Statistics
Valuation metrics
Market Cap 1.75B
Enterprise value 1.94B
Trailing P/E (ttm) 4.23
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 7.33
Price/Book (mrq) 0.59
Enterprise Value/Revenue 8.09
Enterprise Value/EBITDA 211.35
Overview
Shares outstanding 500M
Float 350M
Shares short -
% Held by insiders 0.17%
% Held by institutions 0.04%
Average volume (10 days) 23.11M
Average volume (90 days) 34.45M
Price summary
52-Week low 2.86
52-Week high 5.08
Beta 0.32
50-Day moving average 3.87
200-Day moving average 3.65
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 500:100
Last split Date 19 Mar 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 3.68%
Operating margin 0.05%
Operational effectiveness
Return on assets -0%
Return on equity 0.34%
Income Statement
Revenue (ttm) 239.56M
Revenue per share (ttm) 0.48
Quarterly revenue growth (yoy) 0.42%
Gross profit (ttm) 81.3M
EBITDA 30.74M
Net income to common (ttm) 881.18M
Diluted EPS (ttm) 0.83
Quarterly earnings growth (yoy) 13.31%
Balance Sheet
Total cash (mrq) 10.45M
Total cash per share (mrq) 0.02
Total debt (mrq) 119.12M
Total Debt/Equity (mrq) 4.02
Current ratio (mrq) 1.38%
Book value per share (mrq) 5.93
Cash Flow
Cash flow statement 154.39M
Levered free cash flow (LFCF) -43.58M
